Literature DB >> 17013646

Frequency of the hemochromatosis gene (HFE) 282C-->Y, 63H-->D, and 65S-->C mutations in a general Mediterranean population from Tarragona, Spain.

Núria Aranda1, Fernando E Viteri, Joan Fernández-Ballart, Michelle Murphy, Victoria Arija.   

Abstract

Three mutations have recently been detected in the hereditary hemochromatosis HFE gene (282C-->Y, 63H-->D, and 65S-->C). To determine their prevalence in a northeastern Spanish Mediterranean population, we studied 812 subjects between 18 and 75 years of age, randomly selected from the electoral roll of three villages. There were no homozygotes for the 282C-->Y or S65D mutations in this sample. For the 63H-->D mutation, 4.8% were homozygotes; 4.3, 32.3, and 2% were heterozygotes for the 282C-->Y, 63H-->D, and 65S-->C mutations, respectively. The prevalence of compound heterozygotes was 2% for 282C-->Y/63H-->D and 0.6% for 63H-->D /65S-->C. We found no significant differences between men and women. In conclusion, 46% of this Mediterranean population of Spain are carriers of at least one of the three mutations that can increase iron absorption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17013646     DOI: 10.1007/s00277-006-0179-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

1.  Predictors of haemoconcentration at delivery: association with low birth weight.

Authors:  N Aranda; B Ribot; F Viteri; P Cavallé; V Arija
Journal:  Eur J Nutr       Date:  2012-12-18       Impact factor: 5.614

2.  Paraoxonase-1 status in patients with hereditary hemochromatosis.

Authors:  Nicola Martinelli; Anabel García-Heredia; Helena Roca; Núria Aranda; Victoria Arija; Bharti Mackness; Michael Mackness; Fabiana Busti; Gerard Aragonès; Juan Pedro-Botet; Federica Pedica; Ivana Cataldo; Judit Marsillach; Jorge Joven; Domenico Girelli; Jordi Camps
Journal:  J Lipid Res       Date:  2013-03-06       Impact factor: 5.922

3.  Hemochromatosis gene status as a risk factor for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; T R Levin; Gladys Block; Laurel Habel; Gregory J Rumore; Charles Quesenberry; Patricia Buffler
Journal:  Dig Dis Sci       Date:  2008-05-10       Impact factor: 3.199

4.  Frequency of mutations related to hereditary haemochromatosis in northwestern Poland.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Janina Suchy; Iwona Zawada; Jan Lubinski; Piotr Milkiewicz
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

5.  Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.

Authors:  Núria Aranda; Fernando E Viteri; Carme Montserrat; Victoria Arija
Journal:  Ann Hematol       Date:  2010-01-28       Impact factor: 3.673

6.  Adapting prenatal iron supplementation to maternal needs results in optimal child neurodevelopment: a follow-up of the ECLIPSES Study.

Authors:  Lucía Iglesias-Vázquez; Carmen Hernández-Martínez; Núria Voltas; Josefa Canals; Pilar Coronel; Mercedes Gimeno; Victoria Arija
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-17       Impact factor: 3.105

7.  Adapting iron dose supplementation in pregnancy for greater effectiveness on mother and child health: protocol of the ECLIPSES randomized clinical trial.

Authors:  Victoria Arija; Francesc Fargas; Gemma March; Susana Abajo; Josep Basora; Josefa Canals; Blanca Ribot; Estefania Aparicio; Nuria Serrat; Carmen Hernández-Martínez; Núria Aranda
Journal:  BMC Pregnancy Childbirth       Date:  2014-01-18       Impact factor: 3.007

8.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.